Cite
HARVARD Citation
Yokozeki, H. et al. (2021). A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis. Journal of dermatology. 48 (3), pp. 279-288. [Online].